Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001956050-22-000002
Filing Date
2022-11-25
Accepted
2022-11-25 18:14:22
Documents
1
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3546
  Complete submission text file 0001956050-22-000002.txt   4958
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Issuer) CIK: 0001652724 (see all company filings)

EIN.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address
Narido Richard Clavano (Reporting) CIK: 0001956050 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39976 | Film No.: 221420918